12:00 AM
 | 
Sep 24, 2001
 |  BC Week In Review  |  Clinical News  |  Clinical Results

: Phase II results; Phase III

Results of a Phase II study of (R,R)-formoterol in 340 patients showed that patients given study drug had improvements in FEV1 of 24%-27%, which...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >